Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, January 2005, p. 198-201, Vol. 12, No. 1
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.1.198-201.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute of Medical Molecular Biology, Nanjing Medical University, Nanjing,1 The Key Lab on Molecular Biology of Parasites, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu,2 Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China3
Received 5 August 2004/ Returned for modification 8 September 2004/ Accepted 13 September 2004
|
|
|---|
|
|
|---|
For clinical purposes, toxoplasmosis can be divided for convenience into five infection categories: (i) those acquired by immunocompetent patients, (ii) those acquired during pregnancy, (iii) those acquired congenitally, (iv) those acquired by or reactivated in immunodeficient patients, and (v) ocular infections. In any category, clinical presentations are not specific for toxoplasmosis, and a wide differential diagnosis must be considered. Furthermore, methods of diagnosis and their interpretations may differ for each clinical category.
Diagnosis of T. gondii infection or toxoplasmosis in humans is made by biological, serological, histological, or molecular methods or by some combination of these. Clinical signs of toxoplasmosis are nonspecific and are not sufficiently characteristic for a definite diagnosis. In fact, toxoplasmosis mimics several other infectious diseases. Detection of T. gondii antibodies (mainly immunoglobulin G [IgG] and IgM) in patients may aid diagnosis. IgG antibodies usually appear within 1to 2 weeks of acquisition of the infection, peak within 1 to 2 months, decline at various rates, and usually persist for life (6, 8). IgM antibodies may appear earlier and decline more rapidly than IgG antibodies, so the detection of IgG antibodies may be helpful for diagnosis of chronically infected patients, if IgM antibodies are negative. An IgM test is still used by most laboratories to determine if a patient has been infected recently or in the distant past; because of the hurdles posed in interpreting a positive IgM test result, confirmatory testing should always be performed (3, 9, 17).
There are numerous serological procedures available for the detection of humoral antibodies; these include the Sabin-Feldman dye test, the indirect hemagglutination assay, the indirect fluorescent antibody assay, the direct agglutination test, the latex agglutination test, the enzyme-linked immunosorbent assay (ELISA), and the immunosorbent agglutination assay test (13). Most of these immunodiagnostic tests are not easy to apply in the field, e.g., the ELISA or the indirect fluorescence antibody assay, since these techniques require special equipment and reagents. Performing any of these tests even in the laboratory generally takes time, sometimes with overnight incubation steps; otherwise, enzyme reagents would need a cold chain for delivery. In such situations, a rapid, simple, and inexpensive colorimetric assay with robust reagents and no instrumentation could have many diagnostic applications.
In this study, the dipstick dye immunoassay (DDIA) for detection of IgG or IgM antibodies of human toxoplasmosis was developed, sheep anti-human IgG or rabbit anti-human IgM conjugated with a colloidal dye produced in China served as the color-detecting reagents, and a soluble antigen of tachyzoites of T. gondii strain RH (TSA) on a nitrocellulose paper (NCP) membrane dipstick was used as the capture antigen. The DDIA assay for the detection of IgG or IgM antibodies of human toxoplasmosis was found to be rapid, simple, cheap, and effective.
|
|
|---|
Antibodies for labeling and quality control. Sheep anti-human IgG (IgG fragment of antiserum) was obtained from the Sino-American Biotech Company; the concentration of protein was 5 mg/ml. Rabbit anti-human IgM (IgG fragment of antiserum) (Sigma) was purchased from the Beijing Superior Chemical & Instruments Co., Ltd.; the protein concentration was 4 mg/ml. Sheep anti-rabbit IgG and rabbit anti-sheep IgG were purchased from the Beijing Biodee Biotech Co., Ltd.; the protein concentration of each was 2 mg/ml.
Antigen preparation. The original inocula of T. gondii RH strain were peritoneal exudates from infected mice maintained in our laboratory. The exudates selected contained >108 Toxoplasma tachyzoites/ml. Each mouse was inoculated with 0.2 ml of the exudates, the mice were sacrificed 3 days later, and the peritoneal exudates were collected. The exudates were washed three times with physiological saline. The exudates were then filtered through a glass fiber column and then through a CF-11 cellulose column. The purified Toxoplasma tachyzoites were resuspended in phosphate-buffered saline (PBS), and freeze-thawed five times in a refrigerator at 20°C and a 37°C water bath. Exudates were sonicated and centrifuged, and the supernatant was collected as a soluble antigen of Toxoplasma tachyzoites (TSA). The concentration of TSA was 1.2 mg/ml as measured by a spectrophotometer, and then the concentration of TSA was adjusted to 1 mg/ml with physiological saline.
Colloidal dye preparation. The colloidal dye (D-1) produced in China was used as described previously (18). The stock colloidal dye D-1 suspension was prepared as described by Snowden and Hommel (15). Briefly, 0.5 g of D-1 dye was suspended in 30 ml of deionized water and stirred overnight at room temperature. The suspension was washed six times by centrifugation at 20,000 x g for 30 min at room temperature, and the pellet was resuspended in an equal volume of double-distilled water. Aggregated colloidal particles were removed by low-speed centrifugation (500 x g; 30 min). This stock colloidal dye solution, with 0.01% thimerosal added as a preservative, was stored at 4°C.
Labeling sheep anti-human IgG or rabbit anti-human IgM with colloidal dye D-1. A total of 5 ml of prepared dye suspension was mixed with 100 µl of sheep anti-human IgG (5 mg/ml) or 125 µl of rabbit anti-human IgM (4 mg/ml). The mixture was incubated overnight at room temperature. Then, bovine serum albumin was added at a final concentration of 5% to the mixture for another 2 h, after which it was centrifuged at 18,000 rpm for 30 min. The pellet was washed twice with PBS and dispersed in 5 ml of PBS with 0.01% thiomersol.
Dipstick preparation. NCP membranes were purchased from Millipore (Bedford, Mass.). The dipsticks were prepared from NCP (3.0 by 0.3 cm). At the top and bottom of the dipstick, paper pads of 2.0 and 0.5 cm, respectively, were attached. At 1.0 cm from the bottom of the NCP, a band of TSA (about 3 µl per each band, at a concentration of 1 mg/ml) was applied as the detection band. At sites that were 1.0 cm from the top, another band of rabbit anti-sheep IgG (for IgG detection) or sheep anti-rabbit IgG (for IgM detection) was added as a control band.
IgG-DDIA and IgM-DDIA. The IgG-DDIA kit included the sheep anti-human IgG conjugated with dye, prepared dipsticks (the control band was rabbit anti-sheep IgG), and cups, while the IgM-DDIA kit included the rabbit anti-human IgM conjugated with dye, prepared dipsticks (the control band was sheep anti-rabbit IgG), and cups. The detection procedure for the IgG-DDIA and IgM-DDIA was as follows: 10 µl of serum sample was placed in a small plastic cup (0.6 by 1.0 cm), and 50 µl of antibody-conjugated dye was added and mixed. The prepared dipstick was inserted in the cup for 5 to 15 min at room temperature. If both the detection band and the control band were colored purple-blue, the sample was recorded as positive. If the control band was colored purple-blue but the detection band was not colored, it was recorded as negative. If neither band was colored, the test reagents were assumed to be invalid (Fig. 1).
![]() View larger version (173K): [in a new window] |
FIG. 1. Examples of positive and negative results of IgG-DDIA and IgM-DDIA. NG, negative IgG-DDIA; NM, negative IgM-DDIA; PG, positive IgG-DDIA; PM, positive IgM-DDIA.
|
Stability of DDIA. The stability of the dye-antibody conjugation was monitored as follows: the dye-antibody conjugation was stored at 4°C and checked after 1, 2, and 6 months and at room temperature after 1, 2, 3, and 4 weeks. The stability of the dipstick was monitored as follows: the dipstick was placed at in a refrigerator at 4°C for 6 months and at room temperature for 4 weeks.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Sensitivity and specificity test of IgG- and IgM-DDIAa
|
|
View this table: [in a new window] |
TABLE 2. Comparison of detection results obtained by DDIA and ELISA
|
|
|
|---|
In the past, a number of modifications to the ELISA have been described in efforts to produce a more field-applicable assay format. The dot immunobinding assay, using an NCP membrane as a test matrix, is becoming widely used in simple qualitative research applications (11, 14). Colloidal gold-labeled antibodies are also used in dot blot assays to avoid use of the sometimes-problematic enzyme-labeled detecting antibodies (7, 10). Recently, some colloidal dye particles were screened to label antigen or antibody for the detection of antibody or antigen (5, 15, 19); compared with gold or enzyme, the colloidal dye is cheaper or easier to preserve. The colloidal dye particle technique utilizes the concepts of ELISA, dot blot assays, colloidal dye-labeled antigen or antibody, and immunochromatography to produce an inexpensive, robust, NCP-based dipstick test for antibody or antigen detection. Since it requires no instrumentation for qualitative detection of antigen or antibody, it has many potential field applications.
Previously, our laboratory used schistosome antigen conjugated with a colloidal dye produced in China to detect antibody on a NCP membrane dipstick based on immunochromatography. The DDIA for detecting antibody in patients with schistosomiasis showed very high sensitivity, specificity, and positive predictive value. The assay for detection of schistosomiasis in areas where the disease is endemic was found to be rapid, simple, cheap, and effective (19).
In this study, we successfully applied the blue colloidal dye particles (D-1) to label sheep anti-human IgG or rabbit anti-human IgM to detect IgG or IgM antibodies to human toxoplasmosis. To demonstrate the use of the IgG-DDIA and IgM-DDIA, 25 IgG- and IgM-positive serum samples and 50 serum samples from healthy subjects were tested and resulted in high sensitivity and good specificity. In comparing the two tests, there was no significant difference in sensitivity and specificity, but the DDIA was faster and much easier to perform than the commercial ELISA kit. The preparation and use of dye-antibody conjugations is similar to or even simpler than antibody-colloidal gold particle probes. The dye-labeled antibodies can maintain reactivity for at least 6 months when stored at 4°C in a liquid suspension, and the dipstick can also keep its detective capacity after storage at 4°C for at least 6 months.
It is important to mention that the presented data are only preliminary, but they give us a first impression about the suitability of such a test system for routine diagnostics. In other words, the DDIA which utilize sheep anti-human IgG or rabbit anti-human IgM-colloidal dye conjugates as the agents visualized could also be used for detection of specific antibodies in other infectious diseases, if there were specific detective antigens.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»